Cyclin E1 anticorps (pThr395)
-
- Antigène Voir toutes Cyclin E1 (CCNE1) Anticorps
- Cyclin E1 (CCNE1)
-
Épitope
- pThr395
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Cyclin E1 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Réactivité croisée
- Humain
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogène
- Synthesized peptide derived from Human Cyclin E1 around the phosphorylation site of T395.
- Isotype
- IgG
- Top Product
- Discover our top product CCNE1 Anticorps primaire
-
-
- Indications d'application
- WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:10000,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- Cyclin E1 (CCNE1)
- Autre désignation
- CCNE1 (CCNE1 Produits)
- Synonymes
- anticorps CCNE1, anticorps ccne, anticorps cyclinE, anticorps CCNE, anticorps AW538188, anticorps CycE1, anticorps CYCLE, anticorps Ccne, anticorps cyce2, anticorps cycE3, anticorps cyce, anticorps fa18e07, anticorps wu:fa18e07, anticorps cyclin E1, anticorps cyclin E1 L homeolog, anticorps cyclin E1 S homeolog, anticorps CCNE1, anticorps ccne1, anticorps Ccne1, anticorps ccne1.L, anticorps ccne1.S
- Sujet
- CCNE antibody, Ccne1 antibody, CCNE1_HUMAN antibody, cyclin E variant ex5del antibody, cyclin E variant ex7del antibody, Cyclin E1 antibody, Cyclin Es antibody, Cyclin Et antibody, CyclinE antibody, G1/S specific cyclin E antibody, G1/S-specific cyclin-E1 antibody
- UniProt
- P24864
- Pathways
- Cycle Cellulaire, Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Mitotic G1-G1/S Phases
-